Buy-Herbal drug recall: Kian Pee Wan Capsules
Key facts
- Agency
- U.S. Food and Drug Administration (FDA)
- Program
- Drugs
- Classification
- Class I
- Status
- Ongoing
- Event ID
- 98650
- Recall initiated
- Mar 21, 2026
- Classified by FDA
- Aug 17, 2026
- Posted in Enforcement Report
- Aug 19, 2026
- Recalling firm
- Buy-Herbal
- Firm location
- Flushing, NY, United States
- Initiated by
- Voluntary: Firm initiated
- Firm notified customers by
- Products in this event
- 1
What to do
Compare the product, lot or serial numbers below with what you have. If you use a prescription drug or medical device in this recall, talk to your pharmacist or health care provider before you stop using it, and follow the firm's instructions.
Reason for recall
Marketed Without an Approved NDA/ANDA: Product contains undeclared drug ingredients dexamethasone and cyproheptadine.
What the classification means
- Class I: FDA's most serious category: there is a reasonable probability that using or being exposed to the product will cause serious health problems or death.
About this recall
The firm started this recall on Mar 21, 2026. FDA classified it 149 days later, on Aug 17, 2026. Distribution reported by FDA: Product was sold to individual consumers via ebay third party seller. Buy-Herbal has 2 recalls in our records.
Recalled products (1)
D-0769-2026 Class I Ongoing
Kian Pee Wan Capsules, 30-count bottles
Codes / lots: All lots within expiry.
Quantity: 71 bottles
Source and freshness
- Source
- U.S. Food and Drug Administration (FDA) Enforcement Report, via the openFDA drug enforcement dataset
- Official notice
- FDA Enforcement Report, event 98650
- Raw record
- openFDA API (JSON)
- Dataset last updated by FDA
- Nov 3, 2026
- Imported by RecallRadar
- Nov 4, 2026
Enforcement Report entries describe recalls FDA has classified. They are not always the same as a company press release. If something here differs from FDA's record, FDA's record is correct — please tell us.